EMEA-000496-PIP01-08-M07

Key facts

Invented name
Vipidia
Active substance
alogliptin
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0078/2020
PIP number
EMEA-000496-PIP01-08-M07
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of type II diabetes mellitus
Route(s) of administration
Oral use
Contact for public enquiries
Takeda Development Centre Europe Ltd

Tel. +44 20331168000
E-mail: paediatrics@tgrd.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
1 rating